TriSalus Life Sciences, Inc. (NASDAQ:TLSIW – Get Free Report) shares traded up 17.1% during trading on Monday . The stock traded as high as $0.88 and last traded at $0.96. Approximately 1,520 shares were traded during trading, a decline of 69% from the average session volume of 4,945 shares. The stock had previously closed at $0.82.
TriSalus Life Sciences Stock Down 8.5%
The firm’s 50 day moving average is $0.89 and its 200-day moving average is $0.89.
Institutional Trading of TriSalus Life Sciences
An institutional investor recently bought a new stake in TriSalus Life Sciences stock. State Street Corp acquired a new stake in shares of TriSalus Life Sciences, Inc. (NASDAQ:TLSIW – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor acquired 610,963 shares of the company’s stock, valued at approximately $2,780,000.
About TriSalus Life Sciences
TriSalus Life Sciences, Inc is a clinical-stage medical device company focused on developing minimally invasive technologies to enhance the precision and efficacy of cancer radiation therapy. The company’s lead product, the TriMark™ Tissue Marker System, is designed to provide high-visibility soft-tissue fiducial markers that assist oncologists in accurately targeting tumors during radiotherapy. By deploying bio-absorbable markers directly into tumor beds, TriSalus aims to improve treatment planning, patient comfort and long-term follow-up imaging.
Founded in 2015 and headquartered in Plymouth, Minnesota, TriSalus Life Sciences pursues a platform approach to oncology treatment, with research and development efforts centered on novel delivery devices and advanced imaging solutions.
Further Reading
- Five stocks we like better than TriSalus Life Sciences
- Chips to Bots: Qualcomm’s Agentic AI Breakout
- Ciena Fell 40%—Now One Analyst Sees 50% Upside
- Energy Transfer Taps the AI Power Boom
- Viking’s Obesity Edge May Be Staying Power, Not Weight Loss
Receive News & Ratings for TriSalus Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for TriSalus Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
